Audited Results of Shukra Pharmaceuticals Ltd. Company

(Rs in Cr.)	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Operating Income	56.71	32.59	74.57	58.83	20.49
Manufacturing Expenses	0	0	0	0	0
Personnel Expenses	7.04	6.11	5.65	4.89	4.90
Selling Expenses	0	0.01	0.04	0.01	0
Administrative Expenses	5.10	5.63	5	3.25	2.35
Expenses Capitalised	0	0	0	0	0
Cost Of Sales	27.98	19.86	55.17	53.47	17.60
Operating Profit	28.72	12.73	19.40	5.36	2.89
Other Recurring Income	4.58	4.21	2.82	1.20	0.08
Adjusted PBDIT	33.31	16.94	22.22	6.56	2.97
Financial Expenses	1.09	0.59	0.28	0.28	0.29
Depreciation	3.44	3	2.05	1.84	1.66
Other Write offs	0	0	0	0	0
Adjusted PBT	28.77	13.34	19.88	4.44	1.02
Tax Charges	6.72	3.76	1.35	0.04	0.27
Adjusted PAT	22.05	9.58	18.54	4.41	0.75
Non Recurring Items	0	0	0.01	-0.01	0
Other Non Cash adjustments	0	0	0	0	0
Reported Net Profit	22.05	9.58	18.54	4.41	0.75
Equity Dividend	0	0	0.07	0.08	0
Preference Dividend	0	0	0	0	0
Retained Earnings	22.05	47.14	37.59	19.10	14.78

Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article